Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
Final Thoughts Are you prepared to change your body into something youve only dreamed of
Treatment of diseases associated with impaired appetite regulation e.g
Lillys currently approved injection, Zepbound, and Novo Nordisks Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lillys oral obesity pill, Foundayo, has delivered about 11% weight loss
Foundayo is approved for: Adults with a BMI of 30 or higher (obesity classification) Adults with a BMI of 27 or higher who also have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or abnormal cholesterol Foundayo is not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, consistent with other GLP-1 receptor agonists
US$ 29.66
US$ 20.37
US$ 29.86
US$ 25.73
